78 related articles for article (PubMed ID: 15588989)
21. Characterization of the receptors for axon guidance factor netrin-4 and identification of the binding domains.
Qin S; Yu L; Gao Y; Zhou R; Zhang C
Mol Cell Neurosci; 2007 Feb; 34(2):243-50. PubMed ID: 17174565
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
[TBL] [Abstract][Full Text] [Related]
23. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K
J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162
[TBL] [Abstract][Full Text] [Related]
24. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
25. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta.
Pariser H; Perez-Pinera P; Ezquerra L; Herradon G; Deuel TF
Biochem Biophys Res Commun; 2005 Sep; 335(1):232-9. PubMed ID: 16105548
[TBL] [Abstract][Full Text] [Related]
26. The receptor phosphatase HmLAR2 collaborates with focal adhesion proteins in filopodial tips to control growth cone morphology.
Baker MW; Peterson SM; Macagno ER
Dev Biol; 2008 Aug; 320(1):215-25. PubMed ID: 18582860
[TBL] [Abstract][Full Text] [Related]
27. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
28. 7TM pharmacology measured by label-free: a holistic approach to cell signalling.
Rocheville M; Jerman JC
Curr Opin Pharmacol; 2009 Oct; 9(5):643-9. PubMed ID: 19671497
[TBL] [Abstract][Full Text] [Related]
29. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
30. Proteolytic processing of the receptor-type protein tyrosine phosphatase PTPBR7.
Dilaver G; van de Vorstenbosch R; Tárrega C; Ríos P; Pulido R; van Aerde K; Fransen J; Hendriks W
FEBS J; 2007 Jan; 274(1):96-108. PubMed ID: 17147696
[TBL] [Abstract][Full Text] [Related]
31. Identification of a ligand for IgG-Fc derived from a soluble peptide library based on fusion proteins secreted by S. cerevisiae.
Mersich C; Billes W; Jungbauer A
Biotechnol J; 2007 Jun; 2(6):672-7. PubMed ID: 17492714
[TBL] [Abstract][Full Text] [Related]
32. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
33. Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.
Mohebiany AN; Nikolaienko RM; Bouyain S; Harroch S
FEBS J; 2013 Jan; 280(2):388-400. PubMed ID: 22682003
[TBL] [Abstract][Full Text] [Related]
34. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
Houtani T; Munemoto Y; Kase M; Sakuma S; Tsutsumi T; Sugimoto T
Biochem Biophys Res Commun; 2005 Sep; 335(2):277-85. PubMed ID: 16083862
[TBL] [Abstract][Full Text] [Related]
35. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
36. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
37. Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.
Craig SE; Brady-Kalnay SM
Anticancer Agents Med Chem; 2011 Jan; 11(1):133-40. PubMed ID: 21235433
[TBL] [Abstract][Full Text] [Related]
38. Receptor protein tyrosine phosphatases as mediators of cellular adhesion.
Beltran PJ; Bixby JL
Front Biosci; 2003 Jan; 8():d87-99. PubMed ID: 12456340
[TBL] [Abstract][Full Text] [Related]
39. Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization.
Rizzo S; Thévenin D
Methods Mol Biol; 2024; 2743():195-209. PubMed ID: 38147217
[TBL] [Abstract][Full Text] [Related]
40. Receptor tyrosine phosphatases in axon growth and guidance.
Bixby JL
Neuroreport; 2000 Jul; 11(10):R5-10. PubMed ID: 10923644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
